Tumor-Induced Osteomalacia (TIO)

2 competing products in clinical development for Tumor-Induced Osteomalacia (TIO).

Pipeline by Phase

Phase 21
Approved1

All Products (2)

ProductCompanyStageStatusHype
KRN23Kyowa KirinApprovedCompleted
43
BurosumabKyowa KirinPhase 2Completed
35